Latest News & Features
Americas
Massachusetts-based biotechnology start-up Pyxis Oncology has secured a licensing deal with Pfizer for two of the pharmaceutical giant’s antibody-drug conjugates. 22 March 2021
Big Pharma
For smaller companies and universities, deciding where to validate a pharma patent can be difficult. Sarah Kostiuk-Smith of Mewburn Ellis looks at the options within the European Patent Convention countries. 22 March 2021
article
The establishment of the US Patent Trial and Appeal Board in 2012 changed the game for patent owners. And while life science patents have not always been under the spotlight, recent trends suggest more such patents are being reviewed than ever before. 22 March 2021
Big Pharma
Genevant Sciences has entered into a licence agreement for Takeda to develop and market a new liver fibrosis treatment. 18 March 2021
Americas
A proposed Teva Pharmaceutical generic drug to treat multiple sclerosis infringes patents relating to Vumerity, according to a lawsuit filed by Biogen and Alkermes. 18 March 2021
Americas
The Federal Trade Commission (FTC) is launching a new international working group in an “imperative” move to better analyse the impact of pharmaceutical mergers. 18 March 2021
article
The Patent Trial and Appeal Board is an important forum for determining a US patent’s validity. Since 2012, when inter partes review of US patents began, the PTAB’s cancellation rate for challenged patents has varied dramatically. 18 March 2021
Big Pharma
The National Collegiate Athletic Association has filed a petition to cancel a urology centre's ‘Vasectomy Mayhem’ trademark ahead of the NCAA’s March Madness Basketball Tournament. 16 March 2021
Big Pharma
Healthcare innovation led patenting activity in 2020 as COVID-19 fuelled a rise in applications, a report by the European Patent Office has revealed. 16 March 2021
Big Pharma
Patents are a key asset for pharmaceutical startups, but where are they choosing to file? Jian Siang Poh and Angus Fairbairn of Marks & Clerk report. 16 March 2021